Startups
Lexogen is a transcriptomics and Next Generation Sequencing company focusing on the development of technologies for complete transcriptome sequencing.
Overview
Location
Austria, Vienna
Employees
201-500
Phone
+43 1 3451212
Founded date
2007
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 26, 2021 | Deep Phenotyping of the Human Liver for NAFLD (NASH) Target Discovery, Upcoming Webinar Hosted by Xtalks | Ochre Bio’s approach is firmly rooted in computational and systems-driven learning. However, the company’s goal is also to decode substantially better, by deep phenotyping of human organs to complement the growing importance of population g... |
| Aug 19, 2020 | Lexogen Launches the New QuantSeq-Pool Kit to Accelerate Digital Gene Expression Profiling Projects |
Reviews 0
FAQ about Lexogen
When was Lexogen founded?
Lexogen was founded in 2007.
What has the press written about Lexogen?
Parsers VC has collected 3 articles mentioning Lexogen, among them “Deep Phenotyping of the Human Liver for NAFLD (NASH) Target Discovery, Upcoming Webinar Hosted by Xtalks” (Mar 26, 2021) and “Lexogen Launches the New QuantSeq-Pool Kit to Accelerate Digital Gene Expression Profiling Projects” (Aug 19, 2020).
Is Lexogen still active?
Yes, Lexogen is active; its latest activity on Parsers VC dates from Oct 13, 2026.